CEO Alice Zhang to Speak at 2017 Forbes 30 Under 30 Summit

Alice Zhang (2017 Forbes 30 Under 30 awardee in science) to speak about Verge Genomics on "When Science Gets Entrepreneurial" panel

September 29, 2017

SAN FRANCISCO — Verge Genomics, a drug discovery company utilizing genomic data for neuroscience therapeutics, announced today that Alice Zhang, its Chief Executive Officer has been invited to speak on the panel "When Science Gets Entrepreneurial" at the 2017 Forbes 30 Under 30 on October 3, 2017, at 4:10pm Eastern Time in Boston, MA. Alice was awarded the honor of Forbes 30 under 30 in Science earlier this year. She will discuss her experience founding and leading Verge and how the company is disrupting traditional drug discovery to bring better therapeutics to patients as quickly as possible.

About Verge Genomics

Verge Genomics is a next-generation drug discovery company that is using human genomic data to accelerate the discovery of treatments for neurodegeneration. Founded by scientists from leading neuro-genomics labs, the Verge team is 13 people including 11 Ph.D.s in machine learning, neuroscience, applied math, biophysics, statistics, and computational biology from UCLA, Stanford, Oxford, UCSF, and the pharmaceutical sector. For additional information, please visit our website at www.vergegenomics.com.